1. Home
  2. MCHP vs IQV Comparison

MCHP vs IQV Comparison

Compare MCHP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microchip Technology Incorporated

MCHP

Microchip Technology Incorporated

HOLD

Current Price

$71.49

Market Cap

43.1B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$269.67

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHP
IQV
Founded
1989
1982
Country
United States
United States
Employees
N/A
93000
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.1B
43.1B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
MCHP
IQV
Price
$71.49
$269.67
Analyst Decision
Buy
Strong Buy
Analyst Count
22
16
Target Price
$85.59
$227.13
AVG Volume (30 Days)
7.3M
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
2.02%
N/A
EPS Growth
2300.00
4.67
EPS
0.37
1.61
Revenue
$5,349,500,000.00
$9,739,000,000.00
Revenue This Year
$8.12
$6.77
Revenue Next Year
$22.55
$5.89
P/E Ratio
$199.81
$162.59
Revenue Growth
34.38
41.60
52 Week Low
$48.52
$154.50
52 Week High
$105.91
$271.80

Technical Indicators

Market Signals
Indicator
MCHP
IQV
Relative Strength Index (RSI) 40.20 65.29
Support Level $63.54 $159.91
Resistance Level $76.06 $271.80
Average True Range (ATR) 1.92 6.15
MACD 0.13 -1.48
Stochastic Oscillator 14.72 69.82

Price Performance

Historical Comparison
MCHP
IQV

About MCHP Microchip Technology Incorporated

Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: